אינג'י 10 מג80 מג טבליות

Riik: Iisrael

keel: heebrea

Allikas: Ministry of Health

Toimeaine:

EZETIMIBE; SIMVASTATIN

Saadav alates:

MERCK SHARP & DOHME ISRAEL LTD

ATC kood:

C10AA01

Ravimvorm:

טבליה

Koostis:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Manustamisviis:

פומי

Retsepti tüüp:

מרשם נדרש

Valmistatud:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapeutiline rühm:

SIMVASTATIN

Terapeutiline ala:

SIMVASTATIN

Näidustused:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Loa andmise kuupäev:

2012-04-30